Internship

Clinical Operations Intern

Confirmed live in the last 24 hours

Neurocrine Biosciences

Neurocrine Biosciences

1,001-5,000 employees

Healthcare

San Diego, CA, USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • Pursuing an undergraduate degree with an interest in biotechnology and/or clinical science
  • Prior experience in the pharmaceutical or biotechnology industry would be an asset but is not required
  • Comfortable with analyzing and summarizing data, working in excel or other similar data programs
  • Familiarity with biopharmaceutical technologies, physical and life sciences, product development, and regulatory approval processes is desirable
  • Ability to work independently with daily check-ins while working collaboratively with Neurocrine staff
  • Demonstrates a high degree of professionalism and organizational capabilities
  • Good verbal and written communication skills
  • Ability to think creatively and be a team player
  • Offer flexibility with a willingness to work on multiple projects simultaneously
  • Bring to the Company a skill set complementary to its technology and development therapeutics
Responsibilities
  • Organizing and performing study level and individual subject level review and analysis of clinical trial data
  • Assisting in review and editing of study-related materials (Informed Consent Forms, Case Report Forms, CRF instructions, site memos, clinical-regulatory documents, vendor specification and site-facing instructions)
  • Preparing reports and presentations
  • Maintaining accurate, detailed trackers; assist in follow up of action items as needed
  • Contributing to study start-up and amendment activities as needed, including testing data systems, reviewing checklists, finalizing study documents and plans
  • Participating in meetings and discussions
  • Collaborating with a mentor team of cross-functional team members as well as the other interns in the class
  • Completing a special project and presenting the recommendations to senior management upon completion
Neurocrine Biosciences

Neurocrine Biosciences

View

Company Stage

IPO

Total Funding

N/A

Headquarters

San Diego, California

Founded

1992

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Neurocrine's partnership with PANTHERx Rare enhances patient access to CRENESSITY.
  • The expanding specialty pharmacy market supports Neurocrine's distribution strategy for CRENESSITY.
  • FDA's focus on novel therapies may expedite Neurocrine's future drug approvals.

What critics are saying

  • Increased competition in CAH treatments could affect Neurocrine's market share.
  • Potential unidentified side effects of CRENESSITY may lead to regulatory scrutiny.
  • Reliance on PANTHERx Rare for distribution poses a risk if disruptions occur.

What makes Neurocrine Biosciences unique

  • CRENESSITY is the first non-steroidal treatment for classic congenital adrenal hyperplasia.
  • Neurocrine's CRENESSITY offers a novel approach by reducing glucocorticoid doses in CAH patients.
  • The FDA approval of CRENESSITY marks the first new CAH treatment in 70 years.

Help us improve and share your feedback! Did you find this helpful?